Confidental deal

Confidental deal General and orthodontic dentistry

⚔️  🛡️ 🗡️
06/07/2025

⚔️ 🛡️ 🗡️

🌱 🌱 🌱
06/07/2025

🌱 🌱 🌱

In the cutting-edge world of biotechnology, researchers have taken a major step toward eliminating one of humanity’s oldest oral enemies—tooth decay—through the use of nanoparticle-based vaccines. These nanoparticles, structures as small as a billionth of a meter, act like guided missiles, delivering key antigens from the Streptococcus mutans bacteria directly to immune cells. Instead of simply injecting a substance, these vaccines smartly stimulate the immune system to launch a rapid, robust, and long-lasting defense against decay-causing bacteria—like an advanced early warning system for the human mouth.

These nanovaccines are typically made from materials like PLGA (poly-lactic-co-glycolic acid), which are not only biodegradable and safe, but also capable of controlled antigen release. In animal studies, injection of these vaccines led to high levels of IgA antibodies in saliva and IgG antibodies in the bloodstream—immune soldiers that neutralize bacteria before they can settle on teeth.

Researchers hope this technology will soon enter clinical trials and pave the way for the world’s first universal anti-cavity vaccine. Just imagine—a simple childhood vaccine that could offer years of protection for dental health, without the need for constant brushing or costly treatments. Though there’s still a journey ahead, the outlook is promising—a world where children’s smiles are protected from decay from their earliest days, thanks to nanovaccines.

Article Code: PMC10100722

https://pmc.ncbi.nlm.nih.gov/articles/PMC10100722/

10/06/2025

To my valued patients,

Our clinic will be closed on June 11, 2025 and will resume its regular dental services on June 16, Monday.
🦷

🌱 🌱 🌱
24/04/2025

🌱 🌱 🌱

Japanese researchers have initiated the world's first human trial of a drug aimed at regenerating teeth, following successful animal studies where the drug induced new tooth growth without significant side effects. The clinical trial began in October 2024 at Kyoto University Hospital and involves administering the experimental drug to healthy adult males aged 30 to 64 who are missing at least one tooth. The primary objective is to assess the drug's safety profile. This groundbreaking therapy works by suppressing a protein known as USAG-1, which inhibits tooth development; by blocking this protein, the drug stimulates the growth of new teeth from latent tooth buds present in the human jaw. Previous animal studies demonstrated that a single dose of the drug successfully promoted tooth regeneration in mice, ferrets, and dogs. If these human trials confirm the drug's safety and efficacy, researchers anticipate that it could become available for public use by 2030, offering a potential alternative to dentures and implants for individuals with tooth loss.

03/02/2025

Edward Mordrake, born in the 19th century, is remembered for one of the most astonishing anomalies documented in medical history: an additional face on the back of his head. This condition, known as craniofacial duplication or diprosopus, is extremely rare and is characterized by the presence of a partial or complete facial structure on the back of the head. Although the additional face lacked full functionality, such as muscle control or the ability to speak, it was said to be capable of moving its eyes, smiling, and displaying expressions. However, these movements were not connected to the primary brain.

According to accounts of the time, this second face would whisper unsettling things, further exacerbating Mordrake’s mental anguish. 19th-century doctors, constrained by the lack of advanced technology and medical knowledge, were unable to provide adequate treatment for his condition. Isolated and tormented both physically and psychologically, Edward Mordrake took his own life at the age of 23, leaving behind a story that continues to fascinate and perplex the world.

Credits: Conocimientum

15/12/2024

confiDENTALclinic

🌱
14/12/2024

🌱

May pag-asa pa para sa mga gumagamit ng pustiso at implant kung magiging matagumpay ang sinasaliksik na gamot para sa pagtubo ng ngipin. 🦷

Tingnan ang comments section para sa link ng buong detalye.

Treat yourself 🦷
02/11/2024

Treat yourself 🦷

🤓
22/08/2024

🤓

07/08/2024
🛑 ✋
04/06/2024

🛑 ✋

02/06/2024

Hi!
Our clinic will be closed today (03 June 2024, Monday) due to the scheduled power outage.

Salamat po
-confiDENTALclinic

Address

2nd Floor, Espasyo Bldg. , Gen. Tinio Cor. Gen. Natividad
Laur
3129

Opening Hours

Monday 9am - 12pm
1pm - 4pm
Wednesday 9am - 12pm
1:30pm - 4pm
Thursday 9am - 12pm
1:30pm - 4pm
Saturday 9am - 12pm
1:30pm - 4pm

Website

Alerts

Be the first to know and let us send you an email when Confidental deal posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Confidental deal:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram